Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cree, Inc.    CREE   US2254471012

CREE, INC.

 (CREE)

13
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Analysis summary4-Traders Strategies 

Cree, Inc. : End of the technical recovery

11/09/2012 | 09:13am
Opinion : Bearish under 32.1 USD
Target price : 28.6 USD
Stop loss: 33.8 USD
NASDAQ
Semiconductors
The share is meeting an important level. We suggest caution because this point could stop the bullish trend.

From a fundamental viewpoint, firstly, we note the high valuation of the company. PER for the current year is at 46.44x and expected at 26.93x for next year. With a valuation ratio of 2.2x, the group appears overvalued compared to its business activity.

From a technical viewpoint, the proximity of the USD 32.1 medium-term resistance limits the upside potential on the stock. The uptrend in the short term could be stopped by this level and prices could decrease sharply in the coming sessions. Technical indicators also show an overbought situation that reinforces this bearish scenario. Thus, there is a higher downside potential than upside.

The graphical configuration argues to establish a short position at the current price. The end of the technical rebound, the consolidation phase and overbought situation, there are all the characteristics for short selling. The first objective will be fixed near the USD 28.6 short term support and by extension the USD 22.8 area. This strategy should be protected by a stop loss above USD 32.1.

Cree, Inc. : Cree, Inc. : End of the technical recovery
Copyright (c) 2013 4-Traders.com



Partner Area
React to this article
 

Disclaimer : 4-Traders.com is not registered as a securities broker-dealer or investment adviser with any jurisdiction and is not providing any personalized financial, investment or tax advice. 4-Traders cannot assess or guarantee the suitability of any particular investment to any personal situation. Accordingly, you bear complete responsibility for your own investment, financial, and tax research and decisions and should seek the advice of a qualified professional prior to making any decisions based on 4-Traders' website information. This article is provided solely for informational purposes, and does not constitute an offer or solicitation to buy or sell any securities. All opinions expressed and information and data provided therein are subject to change without notice.

Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 7 156 M$ -
Company Value 6 348 M$ 6 197 M$
Valuation 2013e 2014e
PER (Price / EPS) 76,4x 46,3x
Capitalization / Revenue 5,16x 4,32x
EV / Revenue 4,58x 3,74x
EV / EBITDA 20,0x 15,4x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 12,1% 15,4%
operating laverage (Delta EBIT / Delta Sales) 2,19x 2,67x
Net Margin (Net Profit / Revenue) 6,54% 9,36%
ROA (Net Profit / Asset) 3,77% 5,84%
ROE (Net Profit / Equities) 4,81% 6,93%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   6,98% 6,15%
Cash Flow / Sales (Taux d'autofinancement) 12,5% 15,0%
Capital Intensity (Assets / Sales) 1,73x 1,60x
Financial Leverage (Net Debt / EBITDA) -2,54x -2,38x
Income Statement Evolution
Cree, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Cree, Inc. : EPS Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.